Tragara Pharmaceuticals
Carlsbad, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
TM
Thomas M. EstokExecutive
TP
Tracy ParrottExecutive
DB
Dennis BilskiExecutive
Board
EW
EZ
Evgeny Zaytsev, M.D.Board director
AS
Alain SchreiberBoard director
MB
Mauro BoveBoard director
RE
Ralph E. ChristoffersenBoard director
KP
Investors · 1
Reported raises · per SEC filings
Form D private placements$19.8M disclosed across 4 rounds · 2015–2019
▶$2.3MraisedApr 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$2.3MraisedApr 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lynne R. RollinsExecutive Officer
- Eckard WeberDirector
- Dennis PodlesakDirector
- Scott MegaffinExecutive Officer, Director
- Tracy LawhonExecutive Officer
- Thomas M. EstokDirector
- Mauro BoveDirector
- Grigory BorisenkoDirector
- Chris E. ChristoffersenDirector
- Alain SchreiberDirector
- Offering amount
- $12M
- Amount sold
- $2.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedNov 2016 · 3 investors · PharmaceuticalsRule 506(b)
▶$3.3MraisedNov 2016 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Eckard WeberDirector
- Evgeny Zaytsev, M.D.Director
- Alain SchreiberDirector
- Thomas M. EstokExecutive Officer, Director
- Mauro BoveDirector
- Tracy ParrottExecutive Officer
- Dennis BilskiExecutive Officer
- Ralph E. ChristoffersenDirector
- Kim P. KamdarDirector
- Offering amount
- $5.4M
- Amount sold
- $3.3M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.1MraisedSep 2015 · 7 investors · PharmaceuticalsRule 506(b)
▶$13.1MraisedSep 2015 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas M. EstokExecutive Officer, Director
- Mauro BoveDirector
- Alain SchreiberDirector
- Dennis BilskiExecutive Officer
- Tracy ParrottExecutive Officer
- Eckard WeberDirector
- Kim P. KamdarDirector
- Ralph E. ChristoffersenDirector
- Evgeny Zaytsev, M.D.Director
- Offering amount
- $13.1M
- Amount sold
- $13.1M
- Finders' fees
- $50K
- Proceeds to insiders
- $900K
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJul 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedJul 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chris LeMastersExecutive Officer
- Alain SchreiberDirector
- Kim P. KamdarDirector
- Eckard WeberDirector
- Tracy ParrottExecutive Officer
- Evgeny Zaytsev, M.D.Director
- Thomas M. EstokExecutive Officer, Director
- Ralph E. ChristoffersenDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Tragara Pharmaceuticals's investors?
- Tragara Pharmaceuticals's investors include Domain Associates.
- How much funding has Tragara Pharmaceuticals raised?
- Tragara Pharmaceuticals has disclosed $19.8M raised across 4 rounds.
- Where is Tragara Pharmaceuticals headquartered?
- Tragara Pharmaceuticals is headquartered in Carlsbad, US.